In order to study adherence with statin therapy with the new method, we conducted a pharmacokinetic study (N=48 coronary patients), STAT-MON 1, where succeeded developing dose-normalized cut‐off values for statin concentrations and an algorithm for adherence that can accurately discriminate patients who are non-adherent to statins from those who are adherent. The algorithm can potentially be generalizable to other drugs.
During spring 2021, we will conduct a new pharmacokinetic study (N=60 patients), STAT-MON 2, to validate the decision limits developed in STAT-MON 1 study.